MedTrace Logo

Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma

NCT00135642 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2023-09-14

No results posted yet for this study

Summary

The purpose of this study was to assess the effects of grass pollen immunotherapy on symptoms, bronchial hyperresponsiveness and quality of life in seasonal rhinitis and asthma. Hay fever symptoms and medication use, health-related quality of life, and measurements of non-specific bronchial responsiveness were recorded during the study period.

Conditions

  • Rhinitis, Allergic, Seasonal

Interventions

BIOLOGICAL

Subcutaneous Alutard SQ grass pollen (Phleum pratense)

PROCEDURE

Venepuncture: 20 ml blood sample taken on 2 separate visits

Sponsors & Collaborators

  • ALK-Abelló A/S

    collaborator INDUSTRY

  • Imperial College London

    lead OTHER

Principal Investigators

  • Stephen R Durham, Professor · Royal Brompton Hospital, NHLI Imperial College London United Kingdom

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-02-29
Completion
1998-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00135642 on ClinicalTrials.gov